Thu, Apr 27, 2017
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

HFRI Emerging Markets (Total) Index declines by 2.5% in January after gaining 7% in 2013's last four months

Friday, February 28, 2014
Opalesque Industry Update - Hedge funds investing in Latin America and Eastern Europe experienced sharp losses to begin 2014 even as the funds saw strong capital inflows from investors to start the year, according to the latest HFR Emerging Markets Hedge Fund Industry Report, released today by HFR®, the established global leader in indexation, analysis and research for the global hedge fund industry.

Total hedge fund capital invested in Emerging Markets increased by over $9 billion in 4Q 2013 to over $170 billion (Chinese RMB: 1.03 T, Brazilian Real 396 billion, Russian Rubble 6.04 T, Saudi Riyal: 637 billion, Indian Rupee: 10.55 T) with inflows for the quarter of $2.1 billion. For the full year 2013, total hedge fund capital invested in EM increased by nearly $20 billion, on inflows of over $6.4 billion.

While the HFRI Emerging Markets (Total) Index gained +7.1 percent in the final four months of 2013, the Index declined by - 2.5 percent in January on weakness in Eastern Europe and Latin America. The HFRI EM: Latin America Index posted a decline of -1.7 percent in 4Q, and then fell -6.0 percent in January, the worst monthly decline since September 2011, albeit outperforming sharp declines in Latin American equity markets, as the Argentine peso plunged over 20 percent. Similarly, the HFRI EM: Russia/Eastern Europe Index gained +2.3 percent in 4Q but fell -5.4 percent in January, also outperforming the broad market drop in Russia and Turkey, as social and civil unrest in Ukraine resulted in conflicts between protesters and government forces.

Hedge fund performance across other Emerging Markets was mixed through both 4Q and early 2014, with the HFRI EM: Asia ex-Japan Index gaining +6.7 percent in 4Q and +10.6 percent in 2013, despite posting a decline of -1.3 percent in January. This compared to a decline of nearly -7.0 percent of Chinese equities in 2013 and a decline of nearly -4.0 percent in January. Hedge funds investing primarily in the Middle East posted gains in 4Q13, FY13 and January 2014, with the HFRX MENA Index gaining +5.2, +20.7 and +0.5 percent in each period, respectively.

EM hedge funds experienced inflows across most regions in 4Q, led by Emerging Asia, which experienced inflows of $1.1 billion, while funds investing in Latin America experienced a small outflow of $156 million for the quarter. For FY13, inflows were also led by Emerging Asia, which received over $3.0 billion of new capital, bringing hedge fund capital dedicated to Emerging Asia to over $45 billion.

“Hedge funds investing in Ukraine and Argentina have been exposed to tremendous volatility in recent weeks, contributing to an intra-emerging market performance decoupling, with funds investing in Emerging Asia, the Middle East and elsewhere in Latin America producing mixed performance through the recent EM-centric volatility,” stated Kenneth J. Heinz, President of HFR. “As developed markets continue to extract economic stimulus measures led by the U.S. Federal Reserve, it is plausible to expect continued volatility in EM in 2014; however, this volatility is likely to create opportunities for hedge funds well positioned to understand these situations and provide liquidity as these dislocations occur. As EM hedge fund capital has again surpassed record levels, global investors are clearly positioning with sophisticated, hedged strategies designed to preserve capital and capture opportunities created by these fluid situations.”

press release

www.hedgefundresearch.com

Bg

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Alternative asset firm YieldStreet surpasses $100m of loans funded in less than 8 quarters[more]

    Komfie Manalo, Opalesque Asia: Alternative asset investment platform YieldStreet reported that it has surpassed $100m in loans funded in less than eight quarters from accredited investors and single family offices. YieldStreet was founded by Milind Mehere and Michael Weisz. In a

  2. Investing - Investor appetite for high-growth IPOs to be tested, Apollo boosts fund's stock allowance for 'diamonds in the rough', Hedge funds uncertain over outlook for Hargreaves Lansdown[more]

    Investor appetite for high-growth IPOs to be tested From FT.com: The US listings market is poised for a busy week with deals that will test investors' appetite for high-growth - but lossmaking - companies. Eight new listings are scheduled for this week, the most since October of 2016,

  3. Hedge funds holding Puerto Rico bonds are looking at a long battle[more]

    Komfie Manalo, Opalesque Asia: Hedge funds which bought Puerto Rico's distressed debt bonds are facing the prospect of a long road ahead to recover their investments as the Caribbean island is attempting to use a U.S. Congress-approved rule that allows it to exploit a bankruptcy-like proceedings

  4. Other Voices: "Winner-take-all" dynamics and hedge fund investing[more]

    A growing stream of thinking in microeconomics is the concept of "winner-take-all" dynamics. The idea seems simple. A combination of networking economics and classic economies of scale creates situations where there are just a few dominant firms or economic agents who are able to capture significant

  5. Investing - How Chipotle's comeback attracted big data robots and value investors alike[more]

    From Forbes.com: When William Ackman's ailing hedge fund Pershing Square Capital Management bet $1 billion on shares in Chipotle Mexican Grill beginning in July 2016, the stakes couldn't have been higher. Pershing Square was reeling from what would eventually be a near $4 billion loss in drugmaker V